|1|Does Exposing Infants to Peanut Products Influence the Risk of a Peanut Allergy? (27343973)
|2|Peanut Allergy: New Developments and Clinical Implications. (27039393)
Commins S.P.... Kulis M.
|3|Oral immunotherapy for peanut allergy induces eosinophilic esophagitis: three pediatric case reports. (26888330)
Semancik E.... Sayej W.N.
|4|A lurking threat: transfer of peanut allergy through peripheral blood stem cell transplantation. (26904156)
Brauns B.... Mempel M.
|5|Early Peanut Introduction and Prevention of Peanut Allergy in High-Risk Infants: Consensus Communication. (26760846)
|6|Diagnostic Value of Specific IgE to Peanut and Ara h 2 in Korean Children with Peanut Allergy. (26739409)
Kim H.Y.... Kim J.
|7|Oral Immunotherapy for Management of Peanut Allergy in Spanish Children. (27326996)
Vila L.... Amado A.
|8|The diagnostic value of component-resolved diagnostics in peanut allergy in children attending a Regional Paediatric Allergology Clinic. (27255511)
van Veen L.N.... De Groot H.
|9|Anti-hIgE gene therapy of peanut-induced anaphylaxis in a humanized murine model of peanut allergy. (27372563)
Pagovich O.E.... Crystal R.G.
|10|Effect of Avoidance on Peanut Allergy after Early Peanut Consumption. (26942922)
du Toit G.... Lack G.
|11|Omalizumab facilitates rapid oral desensitization for peanut allergy. (27609658)
MacGinnitie A.J.... Schneider L.C.
|12|Immunotherapy using algal-produced Ara h 1 core domain suppresses peanut allergy in mice. (26801740)
Gregory J.A.... Berin M.C.
|13|Cor a 14 is the superior serological marker for hazelnut allergy in children, independent of concomitant peanut allergy. (26666993)
Eller E.... Bindslev-Jensen C.
|14|The IgE and basophil responses to Ara h 2 and Ara h 6 are good predictors of peanut allergy in children. (27516216)
van Erp F.C.... Knulst A.C.
|15|Safety of epicutaneous immunotherapy for the treatment of peanut allergy: AA phase 1 study using the Viaskin patch. (26920463)
Jones S.M.... Benhamou P.H.
|16|Introduction of peanuts in younger siblings of children with peanut allergy: a prospective, double-blinded assessment of risk, of diagnostic tests, and an analysis of patient preferences. (27291651)
BAcgin P.... Des Roches A.
|17|A humanized mouse model of anaphylactic peanut allergy. (27417025)
Burton O.T.... Oettgen H.C.
|18|Clinical Significance of Component Allergens in Fagales Pollen-Sensitized Peanut Allergy in Korea. (27582401)
Park K.H.... Park J.W.
|19|Low dose immunotherapy in very young children to treat peanut allergy. (27599211)
|20|Component-Resolved Diagnosis of Peanut Allergy and Its Possible Origins of Sensitization in China. (27240834)
Ma S.... Yin J.
|21|Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy. (27464222) |2016|
|22|Prevalence and factors associated to peanut allergy in Mexican school children. (27475774)
Bedolla-Barajas M.... Morales-Romero J.
|23|Author response to Marrs etA al., Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal. (26769643)
Anagnostou K.... Clark A.
|24|The evolving story of human leukocyte antigen and the immunogenetics of peanut allergy. (26522257)
Hemler J.A.... Kendall P.L.
|25|Peanut allergy as a trigger for the deterioration of atopic dermatitis and precursor of staphylococcal and herpetic associated infections - case report. (26403117)
Ferreira D.... Dos Santos K.R.
|26|Early introduction of peanut to infants at high allergic risk can reduce peanut allergy at age 5 years. (26385490)
|27|Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial: a critical appraisal. (26769642)
Marrs T.... Perkin M.R.
|28|Component-resolved IgE profiles in Austrian patients with a convincing history of peanut allergy. (25765158)
Ackerbauer D.... Breiteneder H.
|29|Urgent information on peanut allergy: New evidence from the LEAP study. (26775304)
Symon B.... Crichton G.
|30|Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. (25282568)
Brough H.A.... Lack G.
|31|IL-9 is a key component of memory TH cell peanut-specific responses from children with peanut allergy. (25112699)
Brough H.A.... Turcanu V.
|32|HLA-DQB1*02 and DQB1*06:03P are associated with peanut allergy. (23443026)
Madore A.M.... Laprise C.
|33|Filaggrin gene mutation associations with peanut allergy persist despite variations in peanut allergy diagnostic criteria or asthma status. (23684069)
Asai Y.... Clarke A.
|34|Putative peanut allergy-induced urticaria in a dog. (23633716)
Kang M.H.... Park H.M.
|35|Activation of the aryl hydrocarbon receptor suppresses sensitization in a mouse peanut allergy model. (21804081)
Schulz V.J.... Pieters R.H.
|36|Association of genetic variants of CD14 with peanut allergy and elevated IgE levels in peanut allergic individuals. (21277522)
Dreskin S.C.... Song B.
|37|T cell responses to major peanut allergens in children with and without peanut allergy. (20067479)
Flinterman A.E.... Van Hoffen E.
|38|Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy? (20567520)
Lotoski L.C.... HayGlass K.T.
|39|Peanut epitopes for IgE and IgG4 in peanut-sensitized children in relation to severity of peanut allergy. (18234310)
Flinterman A.E.... Shreffler W.G.
|40|Alleviating peanut allergy using genetic engineering: the silencing of the immunodominant allergen Ara h 2 leads to its significant reduction and a decrease in peanut allergenicity. (17784907)
Dodo H.W.... Viquez O.M.
|41|Early clinical predictors of remission of peanut allergy in children. (18234313)
Ho M.H.... Allen K.J.
|42|Clinical pearls and pitfalls: peanut allergy. (15971474)
|43|Towards immunotherapy for peanut allergy. (16264338)
Pons L.... Burks W.
|44|Relevance of casual contact with peanut butter in children with peanut allergy. (12847496)
Simonte S.J.... Sicherer S.H.
|45|Serological characteristics of peanut allergy in children. (14616104)
Bernard H.... Scheinmann P.
|46|Patients with anaphylaxis to pea can have peanut allergy caused by cross-reactive IgE to vicilin (Ara h 1). (12589366)
Wensing M.... Koppelman S.J.
|47|Specific IgE antibodies to peanut in western Sweden--has the occurrence of peanut allergy increased without an increase in consumption? (11421907)
van Odijk J.... Borres M.P.
|48|The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. (11113829)
Vander Leek T.K.... Bock S.A.
|49|HLA class II DRB1, DQB1 and DPB1 genotypic associations with peanut allergy: evidence from a family-based and case-control study. (9515587)
Howell W.M.... Warner J.O.
|50|The production of interferon-gamma in response to a major peanut allergy, Ara h II correlates with serum levels of IgE anti-Ara h II. (8308186)
Dorion B.J.... Leung D.Y.